A brand-new, evidence-based, self-evaluation toolkit to help pharma companies track their levels of patient-centricity
... analysing 2016-2017 feedback from:
- Patient groups describe 9 major attributes that contribute to the process of corporate patient-centricity.
- Every one of the attributes is, in turn, shaped by numerous fundamental factors.
- For each of the fundamental factors, patient-group comments received by PatientView were reframed in the Being Patient-Centric toolkit as questions that the patient groups themselves might well pose to companies. Patient groups pose 139 questions to pharma companies that are seeking to be more patient-centric.
One of the 9 aspects identified by patient groups as being important for corporate patient-centricity.
A patient group issue to evaluate your company’s current performance against.
Answers to all questions should be “yes”.
The attributes, fundamentals, and questions are currently at pilot stage, and are being further validated by testing with patient groups in 2018, when the 2nd edition of Being Patient-Centric will be released